34.78 USD
-0.03 (-0.09%)
34.98 USD
+0.2 (+0.58%)
We assign a fundamental rating of 5 out of 10 to HCP. HCP was compared to 280 industry peers in the Software industry. While HCP has a great health rating, there are worries on its profitability. HCP is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
In the past year HCP was profitable.
In the past year HCP had a positive cash flow from operations.
HCP had negative earnings in each of the past 5 years.
HCP had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of HCP (-7.22%) is comparable to the rest of the industry.
The Return On Equity of HCP (-9.72%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.22% | ||
| ROE | -9.72% | ||
| ROIC | N/A |
ROA(3y)-15.33%
ROA(5y)-17.17%
ROE(3y)-20.37%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 82.09%, HCP belongs to the best of the industry, outperforming 86.93% of the companies in the same industry.
In the last couple of years the Gross Margin of HCP has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for HCP so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 82.09% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.31%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
HCP does not have a ROIC to compare to the WACC, probably because it is not profitable.
HCP has more shares outstanding than it did 1 year ago.
HCP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 9.80 indicates that HCP is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.80, HCP belongs to the best of the industry, outperforming 85.87% of the companies in the same industry.
There is no outstanding debt for HCP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 9.8 |
ROIC/WACCN/A
WACC13.94%
2.3 Liquidity
A Current Ratio of 3.79 indicates that HCP has no problem at all paying its short term obligations.
HCP has a Current ratio of 3.79. This is amongst the best in the industry. HCP outperforms 81.63% of its industry peers.
HCP has a Quick Ratio of 3.79. This indicates that HCP is financially healthy and has no problem in meeting its short term obligations.
HCP has a Quick ratio of 3.79. This is amongst the best in the industry. HCP outperforms 81.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.79 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 247.62% over the past year.
The Revenue has grown by 16.30% in the past year. This is quite good.
HCP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 61.00% yearly.
EPS 1Y (TTM)247.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%333.33%
Revenue 1Y (TTM)16.3%
Revenue growth 3Y40.14%
Revenue growth 5Y61%
Sales Q2Q%18.66%
3.2 Future
The Earnings Per Share is expected to grow by 118.92% on average over the next years. This is a very strong growth
Based on estimates for the next years, HCP will show a quite strong growth in Revenue. The Revenue will grow by 15.37% on average per year.
EPS Next Y509.24%
EPS Next 2Y171.61%
EPS Next 3Y118.92%
EPS Next 5YN/A
Revenue Next Year16.96%
Revenue Next 2Y15.67%
Revenue Next 3Y15.37%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 112.19, HCP can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of HCP is on the same level as its industry peers.
HCP is valuated expensively when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 71.87, HCP can be considered very expensive at the moment.
HCP's Price/Forward Earnings ratio is in line with the industry average.
HCP's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.78.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 112.19 | ||
| Fwd PE | 71.87 |
4.2 Price Multiples
HCP's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 124.32 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
HCP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HCP's earnings are expected to grow with 118.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y171.61%
EPS Next 3Y118.92%
5. Dividend
5.1 Amount
HCP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
34.78
-0.03 (-0.09%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners79.69%
Inst Owner Change-46.95%
Ins Owners3.97%
Ins Owner Change0%
Market Cap7.11B
Revenue(TTM)654.89M
Net Income(TTM)-122.22M
Analysts52
Price Target35.32 (1.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1179.36%
Min EPS beat(2)163.27%
Max EPS beat(2)2195.45%
EPS beat(4)4
Avg EPS beat(4)814.28%
Min EPS beat(4)163.27%
Max EPS beat(4)2195.45%
EPS beat(8)8
Avg EPS beat(8)447.11%
EPS beat(12)12
Avg EPS beat(12)310.7%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.35%
Min Revenue beat(2)3.98%
Max Revenue beat(2)4.72%
Revenue beat(4)4
Avg Revenue beat(4)3.95%
Min Revenue beat(4)3.32%
Max Revenue beat(4)4.72%
Revenue beat(8)8
Avg Revenue beat(8)3.78%
Revenue beat(12)12
Avg Revenue beat(12)5.75%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.2%
EPS NQ rev (1m)-2.58%
EPS NQ rev (3m)22.03%
EPS NY rev (1m)0%
EPS NY rev (3m)42.14%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)1.25%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)1.53%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 112.19 | ||
| Fwd PE | 71.87 | ||
| P/S | 10.86 | ||
| P/FCF | 124.32 | ||
| P/OCF | 104.53 | ||
| P/B | 5.65 | ||
| P/tB | 5.75 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.31
EY0.89%
EPS(NY)0.48
Fwd EY1.39%
FCF(TTM)0.28
FCFY0.8%
OCF(TTM)0.33
OCFY0.96%
SpS3.2
BVpS6.15
TBVpS6.05
PEG (NY)0.22
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -7.22% | ||
| ROE | -9.72% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 82.09% | ||
| FCFM | 8.73% |
ROA(3y)-15.33%
ROA(5y)-17.17%
ROE(3y)-20.37%
ROE(5y)-30.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.31%
GM growth 5Y-0.29%
F-Score6
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 84.44% | ||
| Cap/Sales | 1.65% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.79 | ||
| Quick Ratio | 3.79 | ||
| Altman-Z | 9.8 |
F-Score6
WACC13.94%
ROIC/WACCN/A
Cap/Depr(3y)195.54%
Cap/Depr(5y)361.24%
Cap/Sales(3y)2%
Cap/Sales(5y)2.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)247.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%333.33%
EPS Next Y509.24%
EPS Next 2Y171.61%
EPS Next 3Y118.92%
EPS Next 5YN/A
Revenue 1Y (TTM)16.3%
Revenue growth 3Y40.14%
Revenue growth 5Y61%
Sales Q2Q%18.66%
Revenue Next Year16.96%
Revenue Next 2Y15.67%
Revenue Next 3Y15.37%
Revenue Next 5YN/A
EBIT growth 1Y37.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.63%
EBIT Next 3Y44.51%
EBIT Next 5YN/A
FCF growth 1Y156.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y173.12%
OCF growth 3YN/A
OCF growth 5YN/A
HASHICORP INC-CL A / HCP FAQ
What is the ChartMill fundamental rating of HASHICORP INC-CL A (HCP) stock?
ChartMill assigns a fundamental rating of 5 / 10 to HCP.
What is the valuation status of HASHICORP INC-CL A (HCP) stock?
ChartMill assigns a valuation rating of 3 / 10 to HASHICORP INC-CL A (HCP). This can be considered as Overvalued.
What is the profitability of HCP stock?
HASHICORP INC-CL A (HCP) has a profitability rating of 2 / 10.
Can you provide the PE and PB ratios for HCP stock?
The Price/Earnings (PE) ratio for HASHICORP INC-CL A (HCP) is 112.19 and the Price/Book (PB) ratio is 5.65.
What is the financial health of HASHICORP INC-CL A (HCP) stock?
The financial health rating of HASHICORP INC-CL A (HCP) is 8 / 10.